China Resources Pharmaceutical (03320.HK): China Resources Sanjiu's net profit attributable to shareholders for the first half of the year was 1.815 billion yuan, a decrease of 24.31% year-on-year.

Zhitong Finance APP News, CR Pharmaceutical (03320.HK) announced the unaudited financial performance of its subsidiary CR Sanji for the six months ended June 30, 2025. The company achieved a total operating revenue of RMB 14.81 billion, an increase of 4.99% year-on-year; net profit attributable to shareholders was RMB 1.815 billion, a decrease of 24.31% year-on-year; basic earnings per share were RMB 1.09.